The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Dementia of Alzheimer’s disease and other neurodegenerative disorders—memantine, a new hope
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Oxidants, antioxidants, and the degenerative diseases of aging.
Ames, B. N., Shigenaga, M. K., & Hagen, T. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7915 · Cited by 5,958
Magnesium gates glutamate-activated channels in mouse central neurones
Nowak, L., Bregestovski, P., Ascher, P., Herbet, A., & Prochiantz, A. (1984) · Nature · doi:10.1038/307462a0 · Cited by 4,043
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,658
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Excitatory amino acid neurotoxicity and neurodegenerative disease
Meldrum, B., & Garthwaite, J. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90184-a · Cited by 1,771
Glutamate as a neurotransmitter in the brain: review of physiology and pathology
Meldrum, B. S. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.4.1007s · Cited by 1,667
Tariot, P. N., Farlow, M. R., Grossberg, G. T., Graham, S. M., McDonald, S., Gergel, I., & for the Memantine Study Group (2004) · JAMA · doi:10.1001/jama.291.3.317 · Cited by 1,403
Statins as a newly recognized type of immunomodulator.
Kwak, B., Mulhaupt, F., Myit, S., & Mach, F. (2000) · Nature Medicine · doi:10.1038/82219 · Cited by 1,383
The metallobiology of Alzheimer's disease
Bush, A. I. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00067-5 · Cited by 1,315
Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons
Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C. G., & Simons, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6460 · Cited by 1,166
McShane, R., Areosa Sastre, A., & Minakaran, N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003154.pub5 · Cited by 1,155
Sweatt, J. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00054.x · Cited by 1,131
The Time Course of Glutamate in the Synaptic Cleft
Clements, J. D., Lester, R. A. J., Tong, G., Jahr, C. E., & Westbrook, G. L. (1992) · Science · doi:10.1126/science.1359647 · Cited by 1,087
N-methyl-D-aspartic acid receptor structure and function
McBain, C. J., & Mayer, M. L. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.3.723 · Cited by 976
Metabolic Regulation of Brain Aβ by Neprilysin
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., Gerard, C., Hama, E., Lee, H.-J., & Saido, T. C. (2001) · Science · doi:10.1126/science.1059946 · Cited by 961
Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 961
BDNF and Activity-Dependent Synaptic Modulation: Figure 1.
Lu, B. (2003) · Learning & Memory · doi:10.1101/lm.54603 · Cited by 945
Parsons, C. G., Danysz, W., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00019-2 · Cited by 878
Fassbender, K., Simons, M., Bergmann, C., Stroick, M., Lütjohann, D., Keller, P., Runz, H., Kühl, S., Bertsch, T., von Bergmann, K., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081620098 · Cited by 860
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10
Kojro, E., Gimpl, G., Lammich, S., März, W., & Fahrenholz, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081612998 · Cited by 804
Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity
Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D. A., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37111 · Cited by 762
Erkinjuntti, T., Kurz, A., Gauthier, S., Bullock, R., Lilienfeld, S., & Damaraju, C. V. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08267-3 · Cited by 752
Treatment of Alzheimer's disease; current status and new perspectives
scarpini, E., Schelterns, P., & Feldman, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00502-7 · Cited by 721
Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A
Das, S., Sasaki, Y. F., Rothe, T., Premkumar, L. S., Takasu, M., Crandall, J. E., Dikkes, P., Conner, D. A., Rayudu, P. V., Cheung, W., et al. (1998) · Nature · doi:10.1038/30748 · Cited by 609
Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts
Nicholls, D. G., & Ward, M. W. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01534-9 · Cited by 563
Neuropathologic changes in Alzheimer's disease.
Wenk, G. L. (2003) · PubMed · Cited by 554
Orgogozo, J.-M., Rigaud, A.-S., Stöffler, A., Möbius, H.-J., & Forette, F. (2002) · Stroke · doi:10.1161/01.str.0000020094.08790.49 · Cited by 539
Excitatory amino acids and Alzheimer's disease
Greenamyre, J. T., & Young, A. B. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90143-7 · Cited by 484
Aqueous Dissolution of Alzheimer's Disease Aβ Amyloid Deposits by Biometal Depletion
Cherny, R. A., Legg, J. T., McLean, C. A., Fairlie, D. P., Huang, X., Atwood, C. S., Beyreuther, K., Tanzi, R. E., Masters, C. L., & Bush, A. I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23223 · Cited by 482
NMDA receptor pathways as drug targets
Kemp, J. A., & McKernan, R. M. (2002) · Nature Neuroscience · doi:10.1038/nn936 · Cited by 476
Inflammatory processes in Alzheimer's disease
McGeer, E. G., & McGeer, P. L. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00124-6 · Cited by 472
Suh, Y.-H., & Checler, F. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.469 · Cited by 467
Dementia Associated with the Acquired Immunodeficiency Syndrome
Lipton, S. A., & Gendelman, H. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321407 · Cited by 465
Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning
Schenk, D. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn938 · Cited by 436
The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease
Rogawski, M. A., & Wenk, G. L. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00254.x · Cited by 436
Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation
Choi, Y.-B., Tenneti, L., Le, D. A., Ortiz, J., Bai, G., Chen, H.-S. V., & Lipton, S. A. (2000) · Nature Neuroscience · doi:10.1038/71090 · Cited by 425
Danysz, W., & Parsons, C. G. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.938 · Cited by 404
Galantamine: A Review of its Use in Alzheimer??s Disease
Scott, L. J., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200060050-00008 · Cited by 383
Wilcock, G., M??bius, H. J., & St??ffler, A. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200211000-00005 · Cited by 381
Schoemaker, H., Claustre, Y., Fage, D., Rouquier, L., Chergui, K., Curet, O., Oblin, A., Gonon, F., Carter, C., Benavides, J., et al. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36395-5 · Cited by 371
Excitatory amino acids and synaptic transmission: the evidence for a physiological function
Headley, P. M., & Grillner, S. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90116-p · Cited by 364
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies
Danysz, W., Parsons, C. G., Kornhuber, J., Schmidt, W. J., & Quack, G. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00037-1 · Cited by 322
Parsons, C. G., Quack, G., Bresink, I., Baran, L., Przegalinski, E., Kostowski, W., Krzascik, P., Hartmann, S., & Danysz, W. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00092-k · Cited by 311
Kornhuber, J., Bormann, J., Hübers, M., Rusche, K., & Riederer, P. (1991) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(91)90113-v · Cited by 308
Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40)
Miguel-Hidalgo, J. J., Alvarez, X. A., Cacabelos, R., & Quack, G. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03731-9 · Cited by 265
El Idrissi, A., & Trenkner, E. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09459.1999 · Cited by 232
Harris, M. E., Wang, Y., Pedigo, N. W., Hensley, K., Butterfield, D. A., & Carney, J. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010277.x · Cited by 230
Kornhuber, J., & Weller, M. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00047-9 · Cited by 222
Huperzine A, A Potential Therapeutic Agent for Treatment of Alzheimer's Disease
Bai, D. L., Tang, X. C., & He, X. C. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003375281 · Cited by 216
Antibody-Mediated Resolution of Light Chain-Associated Amyloid Deposits
Hrncic, R., Wall, J., Wolfenbarger, D. A., Murphy, C. L., Schell, M., Weiss, D. T., & Solomon, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64639-1 · Cited by 213
Attenuation of NMDA Receptor Activity and Neurotoxicity by Nitroxyl Anion, NO−
Kim, W.-K., Choi, Y.-B., Rayudu, P. V., Das, P., Asaad, W., Arnelle, D. R., Stamler, J. S., & Lipton, S. A. (1999) · Neuron · doi:10.1016/s0896-6273(00)80859-4 · Cited by 206
Rammes, G., Rupprecht, R., Ferrari, U., Zieglgänsberger, W., & Parsons, C. G. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01872-9 · Cited by 200
Is the Ras-MAPK signalling pathway necessary for long-term memory formation?
Orban, P. C., Chapman, P. F., & Brambilla, R. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01306-x · Cited by 186
Open-Channel Blockers at the Human α4β2 Neuronal Nicotinic Acetylcholine Receptor
Buisson, B., & Bertrand, D. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.3.555 · Cited by 179
gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine
Müller, W. E. G., Schröder, H. C., Ushijima, H., Dapper, J., & Bormann, J. (1992) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(92)90063-2 · Cited by 179
Presenilin-dependent γ-secretase activity modulates thymocyte development
Doerfler, P., Shearman, M. S., & Perlmutter, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161102498 · Cited by 178
Involvement of BDNF Receptor TrkB in Spatial Memory Formation
Mizuno, M., Yamada, K., He, J., Nakajima, A., & Nabeshima, T. (2003) · Learning & Memory · doi:10.1101/lm.56003 · Cited by 170
Olmos, G., DeGregorio‐Rocasolano, N., Regalado, M. P., Gasull, T., Boronat, M. A., Trullas, R., Villarroel, A., Lerma, J., & García‐Sevilla, J. A. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702679 · Cited by 167
ZK200775: A phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma
Turski, L., Huth, A., Sheardown, M., McDonald, F., Neuhaus, R., Schneider, H. H., Dirnagl, U., Wiegand, F., Jacobsen, P., & Ottow, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10960 · Cited by 165
Marvanová, M., Lakso, M., Pirhonen, J., Nawa, H., Wong, G., & Ċastrén, E. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1027 · Cited by 156
Kornhuber, J., & Quack, G. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11785-u · Cited by 156
Barnes, C. A., Danysz, W., & Parsons, C. G. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01241.x · Cited by 149
Porter, R. H. P., & Greenamyre, J. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020614.x · Cited by 146
Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Palmer, G. C. (2001) · Current Drug Targets · doi:10.2174/1389450013348335 · Cited by 145
Non-Cholinergic Strategies for Treating and Preventing Alzheimer??s Disease
Doraiswamy, P. M. (2002) · CNS Drugs · doi:10.2165/00023210-200216120-00003 · Cited by 142
Bryson, H. M., & Benfield, P. (1997) · Drugs & Aging · doi:10.2165/00002512-199710030-00007 · Cited by 136
Frankiewicz, T., Potier, B., Bashir, Z. I., Collingridge, G. L., & Parsons, C. G. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15245.x · Cited by 135
Parsons, C. G., Danysz, W., Bartmann, A., Spielmanns, P., Frankiewicz, T., Hesselink, M. B., Eilbacher, B., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00161-0 · Cited by 133
Dopamine/glutamate interactions in Parkinson's disease
Lange, K. W., Kornhuber, J., & Riederer, P. F. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00043-7 · Cited by 132
Hare, W. A., WoldeMussie, E., Lai, R., Ton, H., Ruíz, G., Feldmann, B., Wijono, M., Chun, T., & Wheeler, L. A. (2001) · Survey of Ophthalmology · doi:10.1016/s0039-6257(01)00200-4 · Cited by 131
Görtelmeyer, R., & Erbler, H. C. (1992) · PubMed · Cited by 121
Estrogen and cognitive aging in women
Sherwin, B. B. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02093-x · Cited by 119
Zajaczkowski, W., Frankiewicz, T., Parsons, C. G., & Danysz, W. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00070-1 · Cited by 112
Evaluation of memantine for neuroprotection in dementia
Jain, K. K. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.6.1397 · Cited by 111
Possible Role for Memantine in Protecting Retinal Ganglion Cells from Glaucomatous Damage
Lipton, S. A. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00008-0 · Cited by 111
Zajaczkowski, W., Quack, G., & Danysz, W. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00716-4 · Cited by 110
Witt, A. S., MacDonald, N. C., & Kirkpatrick, P. N. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1311 · Cited by 100
Wenk, G. L., Danysz, W., & Mobley, S. L. (1995) · European Journal of Pharmacology Environmental Toxicology and Pharmacology · doi:10.1016/0926-6917(95)00028-3 · Cited by 98
Harkany, T., Hortobágyi, T., Sasvári, M., Kónya, C., Penke, B., Luiten, P. G. M., & Nyakas, C. J. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00058-5 · Cited by 97
Arias, C., Arrieta, I., & Tapia, R. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410416 · Cited by 96
Spanagel, R., Eilbacher, B., & Wilke, R. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90023-x · Cited by 94
Mandelkow�, E. (1999) · Nature · doi:10.1038/45095 · Cited by 93
Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease
Бачурин, С. О. (2002) · Medicinal Research Reviews · doi:10.1002/med.10026 · Cited by 92
Kordower, J., Isacson, O., & Emerich, D. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7156 · Cited by 91
Toda, N., Tago, K., Marumoto, S., Takami, K., Ori, M., Yamada, N., Koyama, K., Naruto, S., Abe, K., Yamazaki, R., et al. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00452-8 · Cited by 90
The NMDA Receptor Complex: A Promising Target for Novel Antiepileptic Strategies
Kohl, B., & Dannhardt, G. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372328 · Cited by 89
Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy
Hartmann, S., & bius, H. J. R. M. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200303000-00003 · Cited by 82
No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use
Wenk, G. L., Quack, G., Moebius, H. J., & Danysz, W. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00411-2 · Cited by 81
Stieg, P. E., Sathi, S., Warach, S. J., Le, D. A., & Lipton, S. A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00214-9 · Cited by 79
Analgesic effect of dextromethorphan in neuropathic pain
Petri, K. C. C., Hoem, N., Moberg, E. R., & Mathisen, L. C. (2004) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.0001-5172.2004.0325.x · Cited by 79
Villetti, G., Bergamaschi, M., Bassani, F., Bolzoni, P. T., Maiorino, M., Pietra, C., Rondelli, I., Chamiot‐Clerc, P., Simonato, M., & Barbieri, M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.050039 · Cited by 78
Paul, C., & Bolton, C. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.50 · Cited by 75
Hesselink, M. B., de Boer, B. G., Breimer, D. D., & Danysz, W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018856020583 · Cited by 72
Memantine for the treatment of dementia
Wilcock, G. K. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00486-1 · Cited by 71
Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer's disease
Dominguez, D. I., & Strooper, B. D. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02038-2 · Cited by 69
Potential and Current Use of N-Methyl-D-Aspartate (NMDA) Receptor Antagonists in Diseases of Aging
Le, D. A., & Lipton, S. A. (2001) · Drugs & Aging · doi:10.2165/00002512-200118100-00001 · Cited by 69
Influence of urine pH and urinary flow on the renal excretion of memantine
Freudenthaler, Meineke, Schreeb, Boakye, Gundert-Remy, & Gleiter (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00819.x · Cited by 64
Medical Treatment and Neuroprotection in Traumatic Brain Injury
Clausen, T., & Bullock, R. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397267 · Cited by 64
Areosa, S. A., & Sherriff, F. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003154 · Cited by 62
Two Blocking Sites of Amino-Adamantane Derivatives in Open N-Methyl-d-Aspartate Channels
Sobolevsky, A. I., & Koshelev, S. G. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77844-0 · Cited by 60
Amyloidosis: new strategies for treatment
Hirschfield, G. M., & Hawkins, P. N. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00169-9 · Cited by 54
The effects of mitochondrial failure upon cholinergic toxicity in the nucleus basalis
Wenk, G. L., Danysz, W., & Roice, D. (1996) · Neuroreport · doi:10.1097/00001756-199606170-00001 · Cited by 54
Jarvis, B., & Figgitt, D. P. (2003) · Drugs & Aging · doi:10.2165/00002512-200320060-00005 · Cited by 54
Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer’s disease
Imbimbo, B. P., Martelli, P. R., Troetel, W. M., Lucchelli, F., Lucca, U., Thal, L. J., & The Eptastigmine Study Group (1999) · Neurology · doi:10.1212/wnl.52.4.700 · Cited by 53
Berrino, L., Oliva, P., Massimo, F., Aurilio, C., Maione, S., Grella, A., & Rossi, F. (2003) · European Journal of Pain · doi:10.1016/s1090-3801(02)00086-1 · Cited by 53
Baudy, R. B., Fletcher, H., Yardley, J. P., Zaleska, M. M., Bramlett, D. R., Tasse, R. P., Kowal, D. M., Katz, A. H., Moyer, J. A., & Abou-Gharbia, M. A. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000385w · Cited by 52
Modifications of neuronal phosphorylated τ immunoreactivity induced by NMDA toxicity
Couratier, P., Lesort, M. J., Sindou, P., Esclaire, F., Yardin, C., & Hugon, J. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815108 · Cited by 51
Excitatory mechanisms in retinal ganglion cell death in primary open angle glaucoma (POAG).
Dreyer, E. B., & Grosskreutz, C. (1997) · PubMed · Cited by 49
Kozela, E., Danysz, W., & Popik, P. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01084-6 · Cited by 46
Distinct effects of amantadine and memantine on dopaminergic transmission in the rat striatum
Peeters, M., Maloteaux, J., & Hermans, E. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00398-7 · Cited by 44
Neuroprotective and Cognition‐Enhancing Properties of MK‐801 Flexible Analogs
Бачурин, С. О., Tkachenko, S. N., Baskin, I. I., Lermontova, N. N., Mukhina, T. V., Petrova, L. N., Устинов, А. К., Proshin, A. N., Grigoriev, V. V., Lukoyanov, N., et al. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03629.x · Cited by 41
Is there a future for vaccination as a treatment for Alzheimer's disease?
McGeer, P. L., & McGeer, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00157-4 · Cited by 39
Maldonado, C., Cauli, O., Rodríguez‐Arias, M., Aguilar, M. A., & Miñarro, J. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00044-5 · Cited by 38
A placebo-controlled study of memantine (Ebixa) in dementia of Wernicke-Korsakoff syndrome.
Rustembegovic, A., Kundurović, Z., Šapčanin, A., & Sofic, E. (2003) · PubMed · Cited by 34
Scorer, C. A. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02042-6 · Cited by 32
Alzheimer’s Disease and the Glutamate NMDA Receptor
Doraiswamy, P. M., & MD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4182 · Cited by 30
Calzada, J. I., Jones, B. E., Netland, P. A., & Johnson, D. A. (2002) · Neurochemical Research · doi:10.1023/a:1014854606309 · Cited by 30
Rüther, E., Glaser, A., Bleich, S., Degner, D., & Wiltfang, J. (2000) · Pharmacopsychiatry · doi:10.1055/s-2000-341 · Cited by 30
Владимировна, Б. И., Драволина, О. А., Neznanova, O., Danysz, W., & Bespalov, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00184-9 · Cited by 29
Hesselink, M. B., de Boer, A. G., Breimer, D. D., & Danysz, W. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050201 · Cited by 29
NSAIDs and Alzheimer's disease: how far to generalise from trials?
Breitner, J. C. S. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00498-8 · Cited by 26
Lupp, A., Kerst, S., & Karge, E. (2003) · Experimental and Toxicologic Pathology · doi:10.1078/0940-2993-00280 · Cited by 23
Use of cholinesterase inhibitors for treatment of Alzheimer disease.
Hake, A. (2001) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.68.7.608 · Cited by 22
Hesselink, M. B., Smolders, H., Eilbacher, B., Boer, A. G. D., Breimer, D. D., & Danysz, W. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34933-x · Cited by 20
Saving the Nerve from Glaucoma: Memantine to Caspaces
Naskar, R., Vorwerk, C. K., & Dreyer, E. B. (1999) · Seminars in Ophthalmology · doi:10.3109/08820539909061468 · Cited by 19
Behavioural evaluation of long-term neurotoxic effects of NMDA receptor antagonists
Zajaczkowski, W., Hetman, M., Nikolaev, E., Quack, G., Danysz, W., & Kaczmarek, L. (1999) · Neurotoxicity Research · doi:10.1007/bf03033259 · Cited by 19
Effect of low-affinity NMDA receptor antagonists on electrical activity in mouse cortical slices
Naish, H. J., Marsh, W., & Davies, J. A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01579-0 · Cited by 12
Winblad (1999) · doi:10.1002/(sici)1099-1166(199902)14:2
Cited by
The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives
Wanka, L., Iqbal, K., & Schreiner, P. R. (2013) · Chemical Reviews · doi:10.1021/cr100264t · Cited by 696
TGF- receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis
Ivens, S., Kaufer, D., Flores, L. P., Bechmann, I., Zumsteg, D., Tomkins, O., Seiffert, E., Heinemann, U., & Friedman, A. (2007) · Brain · doi:10.1093/brain/awl317 · Cited by 567
Mechanism of action of memantine
JOHNSON, J., & KOTERMANSKI, S. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.09.007 · Cited by 502
Therapeutic approaches to Alzheimer's disease
Klafki, H.-W., Staufenbiel, M., Kornhuber, J., & Wiltfang, J. (2006) · Brain · doi:10.1093/brain/awl280 · Cited by 362
David, Y., Cacheaux, L. P., Ivens, S., Lapilover, E., Heinemann, U., Kaufer, D., & Friedman, A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2323-09.2009 · Cited by 342
Metadata
- Authors
- Sonkusare, S. K., Kaul, C. L., & Ramarao, P.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 51
- Issue
- 1
- Pages
- 1-17
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2036537324
- Cited by
- 307
- References
- 131
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.